Anthem Biosciences Limited (ANTHEM) Share Analysis
NSE · Healthcare · Healthcare
Anthem Biosciences Limited (NSE: ANTHEM) is an Indian listed company in the Healthcare sector and a constituent of NIFTY 500, NIFTY Midcap 150, NIFTY MidSmallcap 400. As of 14 Nov 2026, the share price was ₹937.00, P/E 83.6, ROE 22.3%.
Get the AI verdict on ANTHEM: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
ANTHEM chart with trendlines
Is ANTHEM a buy right now?
Sign in free for the AI verdict with entry zone, targets and stop-loss.
About Anthem Biosciences Limited
Stored fundamentals as of 14 Nov 2026 — not a live quote. Signed-in analysis uses same-day data.
ANTHEM key facts
| Price and valuation | |
|---|---|
| Share price | ₹937.00 |
| Market cap | ₹52,795 Cr |
| P/E ratio | 83.6 |
| P/B ratio | 16.1 |
| EPS | ₹10.91 |
| Book value per share | ₹58.20 |
| Dividend yield | 0.21% |
| 52-week range | |
| 52-week high | ₹989.10 |
| 52-week low | ₹579.15 |
| Face value | ₹2.00 |
| Shareholding pattern | |
| Promoters | 71.39% |
| FIIs | 3.79% |
| DIIs | 12.1% |
| Public | 12.71% |
Index membership: NIFTY 500, NIFTY Midcap 150, NIFTY MidSmallcap 400.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.